Home / Stocks / IDXX

IDEXX Laboratories (IDXX, Health Care Equipment) Stock Valuation & Fair Value Significantly overvalued

IDEXX Laboratories (IDXX, Health Care Equipment) trades at a blended P/E of 38.4, about 6% below its historical normal valuation, with a forward growth estimate of 12.8% and a PEG of 3.00. Analysts' one-year estimates have been hit 45% of the time.

DATA AS OF 2026-08-21
Blended P/E
38.4
Normal P/E
40.9
PEG
3.00
Fwd growth
12.8%
Div yield
0.0%
RSI (14)
44.9
Neutral

The Street vs SeerForecast

Wall Street's mean price target for IDXX is $698.92 across 13 analysts, 25.5% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-10.

Price and rating by weekClose moved -1.1 percent from 2026-06-10 to 2026-08-17, with 0 rating changes over 20 recorded weeks.2026-06-10: Significantly overvalued, close 556.94 (recalculated)2026-06-14: Significantly overvalued, close 560.88 (recalculated)2026-06-16: Significantly overvalued, close 573.00 (recalculated)2026-06-21: Significantly overvalued, close 562.09 (recalculated)2026-07-02: Significantly overvalued, close 557.80 (recalculated)2026-07-06: Significantly overvalued, close 564.98 (recalculated)2026-07-09: Significantly overvalued, close 558.60 (recalculated)2026-07-12: Significantly overvalued, close 563.57 (recalculated)2026-07-13: Significantly overvalued, close 564.21 (recalculated)2026-07-14: Significantly overvalued, close 540.68 (recalculated)2026-07-20: Significantly overvalued, close 563.81 (recalculated)2026-07-22: Significantly overvalued, close 545.00 (recalculated)2026-07-25: Significantly overvalued, close 544.32 (recalculated)2026-07-27: Significantly overvalued, close 556.20 (recalculated)2026-07-31: Significantly overvalued, close 559.07 (recalculated)2026-08-03: Significantly overvalued, close 559.072026-08-07: Significantly overvalued, close 586.67 (recalculated)2026-08-10: Significantly overvalued, close 586.672026-08-14: Significantly overvalued, close 550.96 (recalculated)2026-08-17: Significantly overvalued, close 550.965575512026-06-102026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-10P/E 40.8-0%Significantly overvalued
2026-06-14P/E 40.8-0%Significantly overvalued
2026-06-16P/E 40.8-0%Significantly overvalued
2026-06-21P/E 40.8-0%Significantly overvalued
2026-07-02P/E 38.7-5%Significantly overvalued
2026-07-06P/E 40.2-2%Significantly overvalued
2026-07-09P/E 40.2-2%Significantly overvalued
2026-07-12P/E 40.5-1%Significantly overvalued
2026-07-13P/E 40.5-1%Significantly overvalued
2026-07-14P/E 40.5-1%Significantly overvalued
2026-07-20P/E 40.7-0%Significantly overvalued
2026-07-22P/E 40.7-0%Significantly overvalued
2026-07-25P/E 38.9-5%Significantly overvalued
2026-07-27P/E 38.9-5%Significantly overvalued
2026-07-31P/E 39.9-2%Significantly overvalued
2026-08-03P/E 39.9-2%Significantly overvalued
2026-08-07P/E 41.8+2%Significantly overvalued
2026-08-10P/E 41.5+2%Significantly overvalued
2026-08-14P/E 40.0-2%Significantly overvalued
2026-08-17P/E 40.0-2%Significantly overvalued
2026-08-21P/E 38.4-6%Significantly overvalued ← now

Frequently asked questions

Is IDEXX Laboratories stock overvalued?

At a blended P/E of 38.4 versus its historical normal P/E of 40.9, IDEXX Laboratories trades about 6% below its typical valuation, with a PEG of 3.00 on 12.8% forward growth. tickerseer currently rates it significantly overvalued.

What is IDEXX Laboratories's fair value and PEG?

IDEXX Laboratories trades at a blended P/E of 38.4 against a historical normal P/E of 40.9, a PEG of 3.00, and a forward growth estimate of 12.8%.

Has tickerseer's rating of IDEXX Laboratories changed?

tickerseer's rating has been significantly overvalued since 2026-06-10.

What is the analyst price target for IDEXX Laboratories?

The mean Wall Street price target for IDEXX Laboratories is $698.92 across 13 analysts, 25.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track IDXX free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.